CVS Health EBITDA 2010-2023 | CVS

CVS Health annual and quarterly EBITDA history from 2010 to 2023. EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.
  • CVS Health EBITDA for the quarter ending December 31, 2023 was $4.507B, a 4.15% decline year-over-year.
  • CVS Health EBITDA for the twelve months ending December 31, 2023 was $18.109B, a 48.7% increase year-over-year.
  • CVS Health 2023 annual EBITDA was $18.109B, a 48.7% increase from 2022.
  • CVS Health 2022 annual EBITDA was $12.178B, a 33.19% decline from 2021.
  • CVS Health 2021 annual EBITDA was $18.227B, a 0.68% decline from 2020.
CVS Health Annual EBITDA
(Millions of US $)
2023 $18,109
2022 $12,178
2021 $18,227
2020 $18,352
2019 $16,358
2018 $12,888
2017 $12,198
2016 $12,861
2015 $11,567
2014 $10,730
2013 $9,907
2012 $8,963
2011 $7,899
2010 $7,606
2009 $7,814
CVS Health Quarterly EBITDA
(Millions of US $)
2023-12-31 $4,507
2023-09-30 $4,817
2023-06-30 $4,338
2023-03-31 $4,447
2022-12-31 $4,702
2022-09-30 $-2,869
2022-06-30 $5,751
2022-03-31 $4,594
2021-12-31 $3,435
2021-09-30 $4,626
2021-06-30 $5,463
2021-03-31 $4,703
2020-12-31 $3,663
2020-09-30 $4,363
2020-06-30 $5,782
2020-03-31 $4,544
2019-12-31 $4,133
2019-09-30 $4,020
2019-06-30 $4,404
2019-03-31 $3,801
2018-12-31 $3,859
2018-09-30 $3,194
2018-06-30 $3,195
2018-03-31 $2,640
2017-12-31 $3,797
2017-09-30 $3,114
2017-06-30 $2,875
2017-03-31 $2,412
2016-12-31 $3,648
2016-09-30 $3,435
2016-06-30 $2,976
2016-03-31 $2,802
2015-12-31 $3,332
2015-09-30 $2,863
2015-06-30 $2,750
2015-03-31 $2,622
2014-12-31 $2,810
2014-09-30 $2,723
2014-06-30 $2,696
2014-03-31 $2,501
2013-12-31 $2,675
2013-09-30 $2,615
2013-06-30 $2,421
2013-03-31 $2,196
2012-12-31 $2,740
2012-09-30 $2,257
2012-06-30 $2,139
2012-03-31 $1,827
2011-12-31 $2,354
2011-09-30 $1,991
2011-06-30 $1,875
2011-03-31 $1,679
2010-12-31 $2,121
2010-09-30 $1,848
2010-06-30 $1,869
2010-03-31 $1,768
2009-12-31 $2,234
2009-09-30 $1,867
2009-06-30 $1,982
2009-03-31 $1,731
Sector Industry Market Cap Revenue
Retail/Wholesale Retail - Drug Stores $86.343B $357.776B
CVS Health Corporation is a pharmacy innovation company. Its offerings include pharmacy benefit management services, mail order, retail and specialty pharmacy, disease management programs, and retail clinics. The Company serves employers, insurance companies, unions, government employee groups, managed care organizations and other sponsors of health benefit plans, and individuals under the CVS Caremark Pharmacy Services, Caremark, CVS Caremark, CarePlus CVS/pharmacy, RxAmerica, Accordant, SilverScript, and Novologix names. CVS Health Corporation, formerly known as CVS Caremark Corporation, is headquartered in Woonsocket, Rhode Island.
Stock Name Country Market Cap PE Ratio
Walgreens (WBA) United States $15.572B 5.11
Herbalife (HLF) Cayman Islands $0.922B 4.18
China Jo-Jo Drugstores Holdings (CJJD) China $0.003B 0.00
GNC Holdings (GNC) United States $0.000B 0.00